<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03079830</url>
  </required_header>
  <id_info>
    <org_study_id>KVIT2016</org_study_id>
    <nct_id>NCT03079830</nct_id>
  </id_info>
  <brief_title>Postoperative Pain Management After Minimally Invasive Aortic Valve Surgery</brief_title>
  <acronym>PPMAMIAVS</acronym>
  <official_title>Efficacy of Ropivacaine Wound Infiltration for Postoperative Pain Management After Minimally Invasive Aortic Valve Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Centre Ljubljana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Centre Ljubljana</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study evaluates the efficacy of local anesthestic application through the catheter in the
      surgical wound for the postoperative pain relief after minimally invasive aortic valve
      surgery. The patients will be enrolled in two different groups according to the protocol of
      the local anesthetic and saline administration:

        1. group: continous infusion of the local anesthetic plus bolus on demand

        2. group: continous infusion of saline plus bolus on demand For all patients metamizol
           every 12 hours plus bolous of piritramid on demand.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing minimally invasive aortic valve replacment surgery will be enroled in the
      study, after giving a signed informed consent.

      The study evaluates the efficacy of local anesthestic application through the catheter in the
      surgical wound for the postoperative pain relief after minimally invasive aortic valve
      surgery.

      Patients will then be randomised in two groups according to the protocol:

        1. group: continous infusion of the local anesthetic plus bolus on demand

        2. group: continous infusion of saline plus bolus on demand

      All patients will receive Metamizol every 12 hours plus bolus of piritramid on demand.

      Analgesia effectivness will be checked hourly according to the visual analogue scale (VAS).
      According to protocol, bolus will be given every time the score of VAS scale is &gt;3.

      The catheter will be removed 48 hours after the protocols' start.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Actual">January 11, 2018</completion_date>
  <primary_completion_date type="Actual">December 31, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of daily cumulative postoperative dose of Piritramid between the two different protocols, using VAS scale to determine level of analgesia.</measure>
    <time_frame>48 hours after admission to the intensive care unit (ICU)</time_frame>
    <description>Comparison of daily cumulative postoperative dose of Piritramid between the two protocols</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications related to the catheter in the surgical wound</measure>
    <time_frame>72 hours after surgery</time_frame>
    <description>Complications related to the catheter in the surgical wound</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale (VAS), frequency of scores higher than 3</measure>
    <time_frame>48 hours after admission to the ICU</time_frame>
    <description>Visual analogue scale (VAS), frequency of scores higher than 3</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Aortic Valve Surgery</condition>
  <condition>Postoperative; Pain</condition>
  <arm_group>
    <arm_group_label>Ropivacaine continous infusion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Piritramid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline continous</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Piritramid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Piritramid</intervention_name>
    <description>Piritramid will be administered i.v., if the patients feel pain after receiving a bolus of Ropivacaine or saline through the catheter.</description>
    <arm_group_label>Ropivacaine continous infusion</arm_group_label>
    <arm_group_label>Saline continous</arm_group_label>
    <other_name>Dipidolor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Piritramid will be administered i.v., if the patients feel pain after receiving a bolus of Ropivacaine or saline through the catheter.</description>
    <arm_group_label>Saline continous</arm_group_label>
    <other_name>Saline Solution</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients after minimally invasive aortic valve surgery

          -  Patients agreement with the study

        Exclusion Criteria:

          -  Age under 18 years

          -  Allergy to local anesthetic
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maja Sostaric, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Clinical department of anesthesiology and intensive care</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Clinical Center Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2016</study_first_submitted>
  <study_first_submitted_qc>March 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2017</study_first_posted>
  <last_update_submitted>February 4, 2018</last_update_submitted>
  <last_update_submitted_qc>February 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Centre Ljubljana</investigator_affiliation>
    <investigator_full_name>Maja Sostaric</investigator_full_name>
    <investigator_title>asoc. prof.</investigator_title>
  </responsible_party>
  <keyword>aortic valve surgery</keyword>
  <keyword>postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Pirinitramide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

